Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - KalVista Pharmaceuticals, Inc. | cbyl-ex321_8.htm |
| EX-31.1 - EX-31.1 - KalVista Pharmaceuticals, Inc. | cbyl-ex311_6.htm |
| EX-31.2 - EX-31.2 - KalVista Pharmaceuticals, Inc. | cbyl-ex312_7.htm |
| 10-K - 10-K - KalVista Pharmaceuticals, Inc. | cbyl-10k_20151231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S‑8 (No. 333-203721) of Carbylan Therapeutics, Inc. of our report dated March 30, 2016 relating to the financial statements, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 30, 2016